During the symposium entitled “What lessons can be drawn from the Covid-19 pandemic for the follow-up of patients with chronic respiratory failure at home – the place of telehealth?“ organized by AGIR à dom as part of the JIVD/ERCA 2022 conference, Laurent Morin, Medical Affairs Director at PhysioAssist, presented the preliminary results of the Homecare…
We are thrilled to share that we will be exhibiting in Lyon next week at the JIVD/ERCA conference 2022, from March 3rd to 5th. The team is so glad and can’t wait to reconnect face-to-face with the pulmonary international medical community! We will showcase our #simeox device and associated support programs, as well as providing the…
We are very proud to announce that PhysioAssist is now MDSAP certified! This tremendous accomplishment represents the result of months of work, led by Jean-Patrick Sanna and Agnés N’dour, respectively QA/RA Director and QA/RA Manager at PhysioAssist. What an achievement! Huge congrats to both of them! 👏 This certification is a strong recognition of our…
Wednesday, November 17th, 2021 – 1:00 PM (CET) -> Register now (required) PhysioAssist is organizing a pre-recorded conference on 17 November at 1pm on the following topic “Pulmonary Rehabilitation. Rehabilitation model in the hospital. The place of Simeox therapy in Post-Covid-19 patients“. Pulmonary Rehabilitation in Post Covid-19 Patients is a crucial topic right now, and…
PhysioAssist is proud to organize a full training day on November 3, 2021 about Post Covid-19 patients care and the place of the Simeox therapy in their Pulmonary Rehabilitation program, in collaboration with Pr Jan Szczegielniak. Pr Jan Szczegielniak and his team have developed a respiratory rehabilitation program for Covid-19 survivors (Szczegielniak J, et al. Post-COVID-19…
This year, the European Cystic Fibrosis Society (ECFS) Digital Conference occurs on 9-12 June 2021. As part of the #ECFS2021 conference program, we are proud to propose the following symposium: “Simeox therapy: a new technology for physiotherapy in CF”. If you have registered to the conference, join us online on Thursday, June 10, 2021 from 10.10…
We are proud and thankful to have been able to gather 8 prestigious clinical teams from 5 different European countries to share their experience on the use of Simeox at each stage of the care of the CF patient. Because we believe best-practices & clinical experience sharing as well as peer-to-peer interaction are of extreme…
The work from Pr Solovic and his team “Feasibility and benefits of an innovative airway clearance device in COPD patients hospitalized for acute exacerbation” will be presented at the 4th World Bronchiectasis Conference next week. 32 patients with AECOPD and symptoms of excessive mucus congestion, were treated during 6 days with medical treatment, pulmonary rehabilitation…
My name is Valérie, I am 39 years old, and I have cystic fibrosis. I was diagnosed when I was 1 year old. Many complications led to a very poor breathing capacity, which necessitated numerous drug interventions through frequent infusions of antibiotics. I discovered Simeox in October 2019, at that time I was desperate with…
We are excited to share that our SIMETOL trial has been published in the European Journal of Respiratory Medicine (“Giovannetti.P, Morin L, Gaubert MR. Safety and Efficacy of an Innovative Airway Clearance Device Versus Manual Chest Physiotherapy Techniques For Airway Secretion Clearance: a Feasibility Study. European Journal of Respiratory Medicine. 2020: 1:2 “). SIMETOL feasibility trial suggests…
USE OF PERSONAL DATA COLLECTED
If you have an account and log on to this site, a temporary cookie will be created to determine if your browser accepts cookies. It does not contain any personal data and will be deleted automatically when you close your browser.
When you log in, we will set a number of cookies to save your login details and screen preferences. The lifetime of a login cookie is two days, that of a screen option cookie is one year. If you check "Remember me", your cookie will be stored for a fortnight. If you log out of your account, the cookie will be deleted.
Certain cookies are exempt from consent: these are cookies and trackers strictly necessary for the provision of a service expressly requested by the user. These include the shopping basket cookie for a merchant site, the session identifier cookie for the duration of a session as mentioned above. Audience measurement solutions, persistent interface personalisation cookies. However, other cookies for audience measurement or operations relating to advertising & social networks require prior consent.
Audience statistics and measurements
The www.physioassist.com website uses Google Analytics and Google Tag Manager to collect the data contained in the cookies. These cookies and tracking tools enable us to analyse behaviour and monitor interactions with the content offered with the aim of continuously improving their quality and user experience. Simply put: we receive this information in aggregate form to help us understand how our site is used, the effectiveness of our marketing campaigns or to help us improve and personalise our site.
The measurement of the audience of the website pages, in order to allow an evaluation of the published content and the ergonomics of the site, without allowing the identification of individuals. The data collected will not be cross-checked with other processing.
The IP address that the cookies may capture is automatically anonymised before integration into Google Analytics to prevent any further use of this personal data or any cross-referencing with other personal information; Finally, the anonymised cookie information will be stored for a period of 13 months.
Advertising and social network operations
PhysioAssist publishes sponsored ads on Facebook and measures the effectiveness of its Google Ads referencing campaigns. The Facebook Pixel cookie allows us to track conversions of our Facebook ads and create retargeting audiences. These two cookies allow us to measure the effectiveness of our marketing actions.
Chatbot « Intercom »
We use a chatbot provided by the company "Intercom" on our site in order to be able to answer your requests directly (support, advice...). By linking the chatbot to Google Tag Manager, we collect your connection information so that we can adapt to the language used by your browser. This information does not make you identifiable. During our exchanges you are sometimes invited, with your consent, to leave us your contact information (Name, email and telephone number) when you wish to be contacted. Without this information or the creation of an account on our site: you remain anonymous.
If you do not wish to be recontacted, or if you have not specified a consent to be sent promotional offers or a newsletter: your information is not kept. Identified chatbot users can access their data at any time (portability principle) and request the deletion of this data (right to forget). To exercise this right, simply write to us directly in the chatbot or to firstname.lastname@example.org or to:
Physio-Assist, 31 parc du Golf – 13100 Aix-en-Provence – France.
Creating an account on physioassist.com or simeoxacademy.physioassist.com
The reason for creating an account on physioassist.com is to access the e-commerce service in order to be able to honour our commercial commitments if you wish to acquire a property or request a quote.
Creating an account on simeoxacademy.com provides private access to healthcare professionals.
Your account access and delivery information are not used for commercial purposes without your consent. Only a voluntary subscription to our newsletter enables us to send you promotional or informative emails other than those resulting from the purchase of a good or a request for a quotation.
Embedded content from other sites
The articles or pages of this site may include embedded content (e.g. videos, images, articles...). Content integrated from other sites behaves in the same way as if the visitor were visiting that other site. In other words, a "Youtube" video viewed on our site counts as viewing on the original platform.
Setting up your navigation software
You can configure your browser software so that cookies are saved in your device or, on the contrary, that they are rejected, either systematically or according to their transmitter. You can also configure your browser software so that you are offered the option of accepting or rejecting cookies from time to time before a cookie is likely to be stored on your device.
How do you exercise your choices, depending on the browser you are using?
The configuration of each browser is different for managing cookies and your choices. It is described in the help menu of your browser, which will enable you to find out how to modify your cookie preferences.